Search methods We searched CENTRAL, MEDLINE, Embase, and LILACS, as well as the WHO ICTRP and ClinicalTrials Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T
Side Effects and Safety Both AOD 9604 and Semaglutide are generally considered safe, but they have different side effect profiles: AOD 9604 : This peptide has minimal reported side effects in clinical studies, making it a safer option for individuals who are sensitive to traditional growth hormone therapy
This finding is particularly significant given that some trials extended to 24 weeks of continuous exposure and included individuals with obesity-related health conditions who might have higher baseline health risks
Research is ongoing
What can I expect during this Weight Loss treatment
Administer IV, IM or SQ